The US government has bought virtually the entire production of the Covid-19 drug Remdesivir for the next three months.
The US Department of Health & Human Services has reached an agreement with the drug's manufacturer, Gilead Sciences, to purchase all its projected production for this month and 90% of production in August and September.
This will make the drug unavailable to Europe and most of the rest of the world.
Remdesivir is expected to be in high demand as one of the only treatments shown to alter the course of Covid-19.
After the intravenously administered medicine helped shorten hospital recovery times in a clinical trial, it won emergency use authorisation in the United States and full approval in Japan.
Covid-19.rehab - the latest news concerning the spread of the SARS-CoV-2 coronavirus (formerly 2019-nCoV), as well as the infectious disease that it causes COVID-19, in separate countries and in the world as a whole. Current news on the topic of coronavirus SARS-CoV-2. Quarantine, pandemic 2020, epidemic: what is it, when will it come to end, precautions and how to protect yourself from this disease. The most honest news, no fakes! To keep up with the latest news, stay tuned for updates on the site! Every day we will collect news and statistics on coronavirus from around the world for you to be aware of this topic.
Owner: SNOWLAND s.r.o.
Registration certificate 06691200
16200, Na okraji 381/41, Veleslavín, 162 00 Praha 6